Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase
Goldenberg, D.M.; DeLand, F.H.
Urologic Clinics of North America 11(2): 277-281
1984
ISSN/ISBN: 0094-0143 PMID: 6328719 Document Number: 223434
Conventional antibodies against prostatic acid phosphatase, labeled with iodine-131, have been administered to patients with prostatic carcinoma for the external scintigraphic imaging of tumors containing prostatic acid phosphatase (radioimmunodetection). The method has been found to be safe and reliable for imaging of primary tumors and non-bone metastases, even differentiating between lung tumors of prostatic and pulmonary origin.
Document emailed within 1 workday
Related Documents
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103Paul, B.D.; Serrano, J.A.; Friedman, A.E.; Sarlos, I.J.; Sternberger, N.J.; Wasserkrug, H.L.; Seligman, A.M. 1977: New agents for prostatic cancer activated specifically by prostatic acid phosphatase Cancer Treatment Reports 61(2): 259-263
Benvenuti, M.; Legnaioli, M.; Melone, F.; Taddei, I.; Tarquini, B. 1983: Circadian rhythm in prostatic acid phosphatase (PAP): a potential tumor marker rhythm in prostatic cancer (PCa) Chronobiologia 10(4): 383-386
Teillac, P.; Leroy, M.; Rabaud, B.; Le Duc, A.; Najean, Y. 1987: Anti-human prostatic acid phosphatase (P.A.P.) monoclonal antibodies: characterisation and practical application Progress in Clinical and Biological Research 243a: 485-487
Hao, X.K. 1993: Radioimmunodetection of prostatic cancer: in vivo 131I-gamma-seminoprotein for diagnosis of prostatic cancer by nuclear imaging Zhonghua Yi Xue Za Zhi 73(11): 655-657; 700
Sheth, A.R.; Garde, S.V.; Mehta, M.K.; Shah, M.G. 1992: Hormonal modulation of biosynthesis of prostatic specific antigen, prostate specific acid phosphatase and prostatic inhibin peptide Indian Journal of Experimental Biology 30(3): 157-161
Leńko, J.; Marczyńska, A.; Kulpa, J.; Kwinta, A.; Bugajski, A. 1986: Biochemical control investigations (determinations of prostatic phosphatase--carcinoembryonic antigen alkaline phosphatase) in patients treated for prostatic carcinoma. Preliminary estimation of effectiveness Materia Medica Polona. Polish Journal of Medicine and Pharmacy 18(4): 238-243
Zattoni, F.; Passerini Glazel, G.; Tasca, A.; Scialino, G.; Cavazzana, A. 1985: Acid phosphatase and prostatic cancer. Survey of present assay methods Minerva Urologica e Nefrologica 37(2): 113-116
Kuriyama, M.; Takahashi, Y.; Kawada, Y. 1990: Clinical significance of prostatic acid phosphatase assay as a tumor marker Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 925-927
González Alenda, F.J.; Castro Beiras, J.M.; Martín Curto, L.M.; Avila Blanco, C.; Crespo Díez, A. 1983: Value of prostatic acid phosphatase and its relation to bone gammagraphy in the diagnosis of cancer of the prostate Revista Clinica Espanola 171(1): 47-50
Chen, L.; Zhu, L.; Wang, K.; Wang, W.; Mei, X.-P.; Liu, T.; Zhang, F.-X.; Wang, W.; Chen, T.; Li, Y.-Q. 2013: Antinociceptive effect of prostatic acid phosphatase in a rat model of cancer-induced bone pain Pain Physician 16(6): 533-546
Nakagami, Y.; Minowa, T.; Tozuka, K.; Hiraoka, Y.; Nakajima, H.; Ishizaki, R.; Mastsumoto, K. 1983: Studies on human prostatic carcinoma cell lines: evaluation of acid phosphatase productivity and effects of sex hormones on the cells Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(9): 1993-1999
Oishi, K.; Arai, Y.; Takeuchi, H.; Yoshida, O. 1993: Side effects of estrogen administration to prostatic cancer patients: clinical and statistical survey of 109 prostatic cancer cases of Kyoto University Hospital Hinyokika Kiyo. Acta Urologica Japonica 39(1): 23-28
Kuriyama, M. 2010: Prostatic acid phosphatase (PAP) Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 7): 747-749
Kuriyama, M. 2005: Prostatic acid phosphatase (PAP) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 8): 702-704
Schubert, J.; Gorski, J. 1983: Zum biologischen Verhalten des Prostatakarzinoms. II: Klinisch-operative Studien zur lymphogenen Metastasierung des Prostatakarzinoms - Le comportement biologique du cancer prostatique. II: Etudes clinicochirurgicales sur les métastases lymphogènes du cancer prostatique - Biological behaviour of prostatic carcinoma. II. Clinical operative studies of lymphatic metastasizing of prostatic carcinoma der Urologe. Ausgabe a 22: 356-359
Yamaguchi, K.; Tanaka, M.; Kitagawa, N.; Kotake, T.; Yanagi, S.; Ito, H. 1989: The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers Hinyokika Kiyo. Acta Urologica Japonica 35(6): 987-991
Lamy, S.; Borsi, C.; Humbel, R. 1983: The value of counterimmunoelectrophoresis for the assay of prostatic acid phosphatase Acta Urologica Belgica 51(3): 340-344
Ablin, R.J. 1979: Immunohistological localization of prostatic acid phosphatase Allergologia et Immunopathologia 7(5): 361-364
Kumamoto, Y.; Tsukamoto, T.; Umehara, T.; Harada, M.; Shimazaki, J.; Fuse, H.; Oshima, H.; Takeuchi, H.; Yoshida, O.; Okada, K. 1990: Clinical studies on endocrine therapy of prostatic carcinoma (3): Histopathological features of prostatic carcinoma and its prognosis Hinyokika Kiyo. Acta Urologica Japonica 36(3): 295-305